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Abstract: Based on the use of phenyl thioether (3S)-7 as a synthetic
equivalent to the N- and a-dianions (3S)-2a, a new carbanionic
approach to trans-(2R,3S)-2-substituted 3-aminopyrrolidines (10) is
described. Application of the method to the asymmetric synthesis of
1-aminopyrrolizidine alkaloid (+)-absouline is also reported.
Key words: asymmetric synthesis, additions, pyrrolidine, carb-
anions, reductive lithiation
2-Lithiopyrrolidines and 2-lithiopiperidines (1, n = 1, 2)
are important intermediates in organic synthesis.1 Al-
though numerous methods have been developed for gen-
erating these synthetically useful intermediates for
asymmetric C-C bond formation at the C-2 of pyrrolidines
and piperidines,2 the formation of 3-heteroatom-substitut-
ed 2-lithiopyrrolidines and 2-lithiopiperidines (2, n = 1, 2)
remains a challenge. The major difficulties associated
with the formation of 3-hydroxypyrrolidine-2-
carbanions3,4 or 3-hydroxypiperidine-2-carbanions are b-
elimination5 and regioselectivity.6 2-Substituted-3-
aminopyrrolidines7,8 in general, and 1-aminopyrroliz-
idines in particular,9 are key structural features in a num-
ber of natural products and/or pharmaceutically
interesting compounds. Examples include compound 3, a
potent and selective 5-HT antagonist for serotonine recep-
tor,9 1-aminopyrrolizidine10,11 alkaloids absouline (4),12,13
isoabsouline (5),12,13 laburnamine (6),14 and loline.15 In
continuation of our interests to develop 3-substituted 2-
lithiopyrrolidine-based synthetic methodologies for alka-
loids syntheses,4,16 we now wish to report the generation
and asymmetric N-a-C-C bond formation reactions of
chiral non-racemic synthon (3S)-2a (2, n = 1,
X = NHCbz) as well as application of the established
method to the asymmetric synthesis of absouline (4,
Figure 1).
Because phenyl thioethers were shown to be valuable
precursors to organolithium reagents via reductive lithia-
tion,17 compound (3S)-7 was considered to be a suitable18
synthetic equivalent to synthon (3S)-2a. Thioether (3S)-7
was envisioned to be prepared from the known protected
3-amino-2-pyrrolidinone (S)-819 (Scheme 1).
Figure 1 Some pharmaceutically interesting 3-aminopyrrolizidines
Scheme 1
Thus, our synthesis commenced with known protected 3-
amino-2-pyrrolidinone (S)-8.19 Chemoselective reduc-
tion20 of (S)-8 with sodium borohydride (NaBH4, MeOH,
–15 °C, 1 h) proceeded smoothly to give N,O-acetal (3S)-
9 as a diastereomeric mixture (yield 96%, Scheme 2).
Treatment of the diastereomers (3S)-9 with thiophenol in
the presence of p-toluenesulfonic acid monohydrate
(TsOH·H2O) and PPTS in dichloromethane (r.t., 30 h) led
to the desired phenyl sulfide (3S)-721 as a single diastereo-
mer (68% yield). Because of the extensive rotamerism,
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With the key carbanion precursor (3S)-7 in hand, the key
reductive lithiation and subsequent nucleophilic reaction
were investigated (Scheme 3). Thus, successive treatment
of (3S)-7 with 1.5 molar equivalents of n-butyllithium and
freshly prepared lithium naphthalenide (3.0 molar equiv,
30 min) at –78 °C, generated the N- and a-dianion (3S)-
2a, which was demonstrated by quenching with methanol
to give the corresponding pyrrolidine 10a in 80% yield
(Table 1, entry 1).
Scheme 3
When the dianion (3S)-2a, generated in situ from (3S)-7,
was trapped with acetone (Table 1, entry 2) the desired
nucleophilic addition occurred, and 10b was obtained in
86% yield, which showed only one diastereomer. Besides,
protonated by-product 10a was isolated in 8% yield. Re-
action of the dianion (3S)-2a with cyclohexanone or cy-
clopentanone proceeded with lower yields, and led in each
case to the formation of one diastereomer (10c and 10d,
Table 1, entries 3, 4). Addition of 2-butanone to 2a yield-
ed two diastereomers (10e) in 47:53 ratio (Table 1, entry
5). Reaction of (3S)-2a with aromatic aldehydes gave the
desired products (10f–h) in higher yields (Table 1, entries
6–8).
Taking into account that reaction of (3S)-2a with symmet-
ric ketones led to only one diastereomer, while its reaction
with unsymmetrical ketones and aldehydes yielded a dia-
stereomeric mixture, it is reasonable to assume that the
reaction proceeds with excellent selectivity at the C-2
position of the pyrrolidine ring and low selectivity at the
exocyclic carbinolic center.
To test the scope of the method, trapping of the dianionic
intermediate (3S)-2a with allylating reagents were inves-
tigated (entries 9, 10). While allylation with allyl bromide
gave poor yield of 10i (40%) {pale yellow oil; [a]D20 –8.4
(c 0.9, CHCl3)}, a 57% yield of 10i was obtained by using
more active allyl iodide as an allylation reagent and by
employing a portion-wise addition protocol of allyl io-
dide.
The extensive rotamerization due to the presence of t-Boc
and Cbz groups in compounds 10b–i, and the absence of
other diastereomers, preclude a straightforward stereo-
chemistry assignment by NMR spectral methods, whereas
on the basis of mechanistic consideration of the carbanion
chemistry,23 it is reasonable to assume that the reductive-
coupling products 10b–i possess trans stereochemistry.
To confirm the stereochemistry of the reaction, and to
demonstrate the power of the method, the asymmetric
synthesis of absouline (4) was envisioned. 1-Aminopyr-
rolizidine alkaloids (+)-absouline (4), (+)-isoabsouline (5)
and their N-oxides were isolated from Nouvelle Calédonie
plants Hugonia oreogena and H. penicillanthemum,12 and
were shown to possess modest antiviral activity. Only one
racemic synthesis of absouline (4)13 has been reported.
Our synthesis started with 10i (Scheme 4). The introduc-
tion of the hydroxyl group was achieved by treating al-
kene 10i with 0.3 molar equivalents of borane dimethyl
sulfide complex in hexane at 25–30 °C for 12 hours, fol-
lowed by hydrogen peroxide oxidation of the trialkylbo-
rane intermediate under basic conditions (3 M NaOH).
The desired terminal alcohol 11 was obtained in 50%
yield. Mesylation (MsCl, Et3N, CH2Cl2, 5 h) of 11 at –40
°C to 0 °C gave mesylate 12 in 90% yield. Treatment of
12 with 3 M HCl solution followed by basification with 1
M NaOH to pH 11–12 furnished, in one pot, the desired
deprotection–cyclisation24 product 13 {yellow oil; [a]D20
+10.8 (c 0.5, CHCl3); lit.10a [a]D20 –18.15 (c 2.7, CHCl3)
for the antipode} in 71% yield. Subjecting of compound
13 to hydrogenolysis conditions (H2 1 atm, 10% Pd/C, 6
M HCl, r.t.) yielded labile 1-aminopyrrolizidine 1410a,11
{[a]D20 +26.5 (c 0.7, MeOH); lit.10a [a]D20 –24.1 (c 5.5,
MeOH) for the antipode} in 78% yield, which was isolat-
ed as its dihydrochloride salt {colorless solid; mp 140–
141 °C (EtOH–Et2O); [a]D20 +15.4 (c 1.2, H2O)}. Finally,
coupling of the free base of (+)-14 with (E)-para-meth-
oxycinnamic acid using DCC as a coupling agent afforded
(+)-absouline (4)25 as a colorless solid, mp 170–171 °C
(EtOAc–PE); [a]D20 +46.0 (c 1.2, CHCl3) {Lit.12 mp
186 °C; Lit.13 amorphous; Lit.12 [a]D +57.0 (c 1.0, CHCl3)
for natural absouline; lit.13 [a]D +26 (c 1.05, CHCl3) for
synthetic (1S,8R)-(+)-absouline and [a]D –34 (c 0.91,
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Table 1 Results of the Reaction between Dianion (3S)-2a and 
Electrophiles21,22




2 MeCOMe 10b (86) 8
3 (CH2)5CO 10c (65) 10
4 (CH2)4CO 10d (56) 12
5 MeCOEt 10e (49) (47:53) 19
6 PhCHO 10f (71) (20:80) 11
7 p-MeOC6H4CHO 10g (72) (39:61) 25
8 2,4-Cl2C6H3CHO 10h (69) (17:83) 16
9 CH2=CHCH2Br 10i (40) 26
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HPLC analysis on a Chiralcel OD-H column (eluent: hep-
tane–EtOH 90:10 + 0.1% Et3N; 0.75 mL/min, l = 290
nm) showed that our synthetic (+)-absouline (4,
tR = 12.011 min) is identical with that of natural
absouline26 (4, tR = 12.009 min). In addition, since racem-
ic 14 has been converted to racemic 5-HT antagonist for
serotonine receptor 39 and alkaloid laburnamine (6),14 re-
spectively, the synthesis of (+)-14 also provides a ready
precursor for the asymmetric synthesis of 3 and labur-
namine (6).
Scheme 4
In summary, protected 3-amino-2-thiophenyl-pyrrolidine
7 was shown to be a valuable synthetic equivalent to dian-
ion 2a. The latter reacted with C-electrophiles to give the
C-C bond formation products 10b–i in 49–86% yields,
with excellent stereoselectivity at the newly formed C-2
stereogenic center. The diprotected (2R,3S)-2-allyl-3-
aminopyrrolidine (10i) was converted to (+)-absouline (4)
in five steps.
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